News &amp; Updates

Efficacy, safety both essential in choosing atypical antipsychotic treatments

A recent study of beliefs and preferences by psychiatrists and psychiatric pharmacists has found that efficacy and safety are equally important when choosing atypical antipsychotic treatments in patients with schizophrenia and bipolar disorders. In addition, they deem that formulary restrictions affect treatment choice and outcomes.

Efficacy, safety both essential in choosing atypical antipsychotic treatments

VTE recurrence similar in patients on DOACs weighing ≥120 vs <120 kg

The recurrence of venous thromboembolism (VTE) is comparable in patients on direct-acting oral anticoagulants (DOACs) weighing ≥120 and those weighing <120 kg, with few events in either group, a recent study has shown.

VTE recurrence similar in patients on DOACs weighing ≥120 vs <120 kg

Antispike nMAb combo reduces viral load in COVID-19 outpatients

11 Mar 2021 by

A combination of two potent antispike neutralizing monoclonal antibodies (nMAbs) – bamlanivimab and etesevimab – significantly reduced viral load in nonhospitalized individuals with mild-to-moderate COVID-19, the phase II/III BLAZE-1* trial has shown.

Antispike nMAb combo reduces viral load in COVID-19 outpatients

GI cancer patients could continue therapy during COVID-19 pandemic

Results of a single-centre study in the UK have suggested that patients receiving systemic anticancer therapy for gastrointestinal (GI) cancers could continue their treatment during the COVID-19 pandemic.

GI cancer patients could continue therapy during COVID-19 pandemic

Extended-release viloxazine for ADHD in kids scores high in phase III trial

The investigational attention-deficit/hyperactivity disorder (ADHD) medication viloxazine extended-release, known as SPN-812, rapidly reduces symptoms in school-aged children with a tolerable safety profile, as shown in the results of a phase III trial.

Extended-release viloxazine for ADHD in kids scores high in phase III trial

YouTube videos of inhaler use omit key steps

Several videos for demonstrating Respimat Soft mist inhaler technique are available through YouTube, but some key steps have been omitted, according to a study, noting that comprehensive and repetitive patient education should be provided and supplemented with reputable online sources.

YouTube videos of inhaler use omit key steps

Chemo continues to benefit UTUC patients, updated POUT analysis shows

In an updated analysis of the phase III POUT* trial presented at ASCO GU 2021, peri-operative chemotherapy continued to improve disease-free survival (DFS) compared with surveillance in patients with upper tract urothelial cancer (UTUC).

Chemo continues to benefit UTUC patients, updated POUT analysis shows

Nivolumab + cabozantinib combo offers better QoL in advanced RCC

First-line treatment with nivolumab plus cabozantinib (NIVO+CABO) led to significantly better patient-reported quality of life (QoL) outcomes compared with sunitinib in patients with advanced renal cell carcinoma (RCC), according to an exploratory analysis of the CheckMate 9ER* trial presented at ASCO GU 2021.

Nivolumab + cabozantinib combo offers better QoL in advanced RCC